BioScrip Reports Second Quarter 2018 Financial Results

Go back to BioScrip Reports Second Quarter 2018 Financial Results

BioScrip (BIOS) Misses Q2 EPS by 2c, Revenues Beat; Offers FY18 EPS Guidance Below Consensus, FY18 Revenue Views In-Line

August 7, 2018 8:09 AM UTC

BioScrip (NASDAQ: BIOS) reported Q2 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $175.8 million versus the consensus estimate of $168.71 million.

Net revenue of $175.8 million, including core product mix of 75.1%, compared to 73.6% in the prior year quarter, reflecting the impact of the implementation of ASC 606*, which resulted in the recognition of amounts previously reported as bad debt expense as a reduction to revenueNet loss from continuing operations of $15.1 million, a $14.0 million... More